Balchem (BCPC) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.39
- EPS estimate
- $1.28
- EPS surprise
- +9.02%
- Revenue surprise
- +5.77%
- Revenue
- $284.0M
- Revenue estimate
- $268.5M
- Reported
- Jul 31, 2026
Balchem reported Q2 2026 results on July 31, 2026. Earnings per share were $1.39, beating the $1.28 estimate by 9.02%. Revenue was $284.0 million, about 6% above the $268.5 million consensus. Compared with Q2 2025, EPS rose about 19% from $1.17 and revenue rose about 11% from $255.5 million.
The longer record shows steady growth after a flat stretch. Annual EPS was $4.04 in 2022 and $3.99 in 2023, then rose to $4.18 in 2024 and $4.75 in 2025. Revenue passed $1 billion in 2025, at $1.04 billion. The first half of 2026 brought $2.64 per share, about 15% more than a year earlier. Q2 2026 set the highs in the table for both EPS and revenue. Over the last 20 quarters, Balchem beat the EPS estimate 18 times. The two misses came in Q3 and Q4 2024.
Balchem reported Q3 between October 21 and November 4 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the growth of recent quarters carries into the second half.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 31, 2026 | $1.28 | $1.39 | +9.02% | $284.0M | SEC |
| Q1 2026 | Apr 30, 2026 | $1.25 | $1.25 | +0.40% | $270.7M | SEC |
| Q4 2025 | Feb 20, 2026 | $1.18 | $1.21 | +2.98% | $263.6M | SEC |
| Q3 2025 | Oct 21, 2025 | $1.16 | $1.24 | +7.36% | $267.6M | SEC |
| Q2 2025 | Jul 31, 2025 | $1.12 | $1.17 | +4.46% | $255.5M | SEC |
| Q1 2025 | Apr 24, 2025 | $1.05 | $1.13 | +8.13% | $250.5M | SEC |
| Q4 2024 | Feb 21, 2025 | $1.06 | $1.03 | −2.37% | $240.0M | SEC |
| Q3 2024 | Oct 25, 2024 | $1.12 | $1.03 | −7.62% | $239.9M | SEC |
| Q2 2024 | Jul 26, 2024 | $1.04 | $1.09 | +5.31% | $234.1M | SEC |
| Q1 2024 | May 3, 2024 | $0.98 | $1.03 | +5.10% | $239.7M | SEC |
| Q4 2023 | Feb 16, 2024 | $0.93 | $0.95 | +2.15% | $228.7M | SEC |
| Q3 2023 | Oct 27, 2023 | $0.97 | $1.04 | +7.22% | $229.9M | SEC |
| Q2 2023 | Jul 28, 2023 | $0.84 | $1.06 | +26.19% | $231.3M | SEC |
| Q1 2023 | Apr 28, 2023 | $0.72 | $0.94 | +30.56% | $232.5M | SEC |
| Q4 2022 | Feb 24, 2023 | $0.80 | $0.94 | +17.50% | $232.5M | SEC |
| Q3 2022 | Nov 4, 2022 | $0.94 | $1.00 | +6.95% | $244.3M | SEC |
| Q2 2022 | Jul 29, 2022 | $0.94 | $1.07 | +13.83% | $236.7M | SEC |
| Q1 2022 | Apr 29, 2022 | $0.82 | $1.03 | +25.61% | $228.9M | SEC |
| Q4 2021 | Feb 18, 2022 | $0.78 | $0.85 | +8.97% | $213.1M | SEC |
| Q3 2021 | Oct 29, 2021 | $0.84 | $0.92 | +9.52% | $197.9M | SEC |
Quarterly revenue
Frequently asked questions
When did Balchem (BCPC) last report earnings?
Balchem last reported on Jul 31, 2026, covering fiscal Q2 2026.
Did BCPC beat earnings estimates?
Yes. Balchem reported EPS of $1.39 for Q2 2026 against a $1.28 estimate — a 9.02% beat.
How much revenue did BCPC report last quarter?
Balchem reported $284.0M in revenue for Q2 2026, against a consensus estimate of $268.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.